Multiple endocrine neoplasia type 2 (MEN2)

RET - multiple endocrine neoplasia type 2

This test is available for the following conditions:

• Conditions > Hearing impairment > Multiple endocrine neoplasia type 2 (MEN2)
• Conditions > Endocrine > Multiple endocrine neoplasia type 2 (MEN2)
• Conditions > Oncogenetics > Multiple endocrine neoplasia type 2 (MEN2)

This product is also part of the following panels:

• WES hereditary cancer (100.0% *)
• WES hereditary cancer (100.0% *)
• WES Mendelian inherited disorders (100.0% *)

* % of the coding region of this gene has a coverage of >20x. (Without % information : This is a non-coding gene for which coverage statistics could not be determined)

Turnaround time
Complete analysis: 8 weeks / Targeted analysis: 4 weeks

Method

• Sequence analysis of selected exons and flanking intron-exon boundaries

Remarks
Analysis of exons 10, 11, 13-16 only. With this test all known mutations are detected and explain 98% of the MEN2 patients.

OMIM: 164761
Performing laboratory: Radboudumc
Authorized material(s): EDTA blood, Isolated DNA, Buccal mucous membrane

---